140 related articles for article (PubMed ID: 7006795)
61. Immunologic markers in the differential diagnosis of non-Hodgkin's lymphomas.
Stein H; Staudinger M; Tolksdorf G; Lennert K
J Cancer Res Clin Oncol; 1981; 101(1):29-42. PubMed ID: 7276070
[No Abstract] [Full Text] [Related]
62. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
Tomić BL
Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
[No Abstract] [Full Text] [Related]
63. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
64. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
65. Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes).
Tolksdorf G; Stein H; Lennert K
Br J Cancer; 1980 Feb; 41(2):168-82. PubMed ID: 7370158
[TBL] [Abstract][Full Text] [Related]
66. Acute lymphoblastic leukemia and non-Hodgkin's lymphoma with mediastinal mass--a study of 23 children; different disorders or different stages?
Shikano T; Arioka H; Kobayashi R; Naito H; Ishikawa Y; Nakadate H; Hatae Y; Takeda T
Leuk Lymphoma; 1994 Mar; 13(1-2):161-7. PubMed ID: 8025517
[TBL] [Abstract][Full Text] [Related]
67. Non-Hodgkin's lymphoma classification: ultrastructural morphometric studies for the quantification of nuclear compartments in situ.
Dardick I; Dardick AM; Caldwell DR; Jeans MT; Bladon T; Setterfield G
Hum Pathol; 1985 Oct; 16(10):1047-60. PubMed ID: 4043954
[TBL] [Abstract][Full Text] [Related]
68. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
69. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
Armitage JO; Vose JM; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec DF
J Clin Oncol; 1989 Dec; 7(12):1783-90. PubMed ID: 2585020
[TBL] [Abstract][Full Text] [Related]
70. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
71. Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphoma.
Garrett JV; Scarffe JH; Newton RK
Br J Haematol; 1979 May; 42(1):41-50. PubMed ID: 380628
[TBL] [Abstract][Full Text] [Related]
72. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets.
Forbes IJ; Zalewski PD; Valente L; Gee D
Clin Exp Immunol; 1982 Feb; 47(2):396-404. PubMed ID: 6978783
[TBL] [Abstract][Full Text] [Related]
73. [Immunopathology of malignant lymphomas (author's transl)].
Huber H; Gattringer C
Arch Geschwulstforsch; 1979; 49(8):694-701. PubMed ID: 317427
[TBL] [Abstract][Full Text] [Related]
74. T cell rich B cell lymphoma (TCRBCL): study of sixteen cases with review of literature.
Muzaffar S; Pervez S; Kayani N; Soomro IN; Hasan SH
Indian J Pathol Microbiol; 1999 Jan; 42(1):15-23. PubMed ID: 10420680
[TBL] [Abstract][Full Text] [Related]
75. Characterization of human peripheral blood lymphocyte cells on the basis of surface properties.
Negro Alvarez JM
Allergol Immunopathol (Madr); 1980; 8(6):679-84. PubMed ID: 7010971
[TBL] [Abstract][Full Text] [Related]
76. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
77. Immunologic surface markers in non-Hodgkin's lymphomas.
Cossman J; Schnitzer B; Deegan MJ
Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
[TBL] [Abstract][Full Text] [Related]
78. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma.
Liu L; Zhang M; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626
[TBL] [Abstract][Full Text] [Related]
79. Lymphoblastic lymphoma/leukemia of T-cell origin: ultrastructural, cytochemical, and immunologic features of ten cases.
Navas Palacios JJ; Valdes MD; Pallares MA; Gomez de Salazar MD; Garcia Marcilla A
Cancer; 1981 Nov; 48(9):1982-91. PubMed ID: 6975156
[TBL] [Abstract][Full Text] [Related]
80. Identification of canine lymphocyte populations by immunofluorescence surface marker analysis.
Chandler JP; Yang TJ
Int Arch Allergy Appl Immunol; 1981; 65(1):62-8. PubMed ID: 7012041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
